Audentes Therapeutics' Incubator/Accelerator Round

Audentes Therapeutics raised a round of funding on January 05, 2015. Investors include JLabs.

Audentes is a biotechnology company committed to the development and commercialization of treatments for people with serious, rare diseases through the application of AAV gene therapy technology. The …

Articles about Audentes Therapeutics' Incubator/Accelerator Round: